Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Transurethral Resection of the Prostate (TURP) Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s transurethral resection of the prostate (TURP) ACS NSQIP performance benchmarked against 458 participating sites.
| Transurethral Resection of the Prostate (TURP) (458 sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 96 | 1.04% | 0.20% |
| 30 Day Morbidity | 96 | 3.13% | 4.26% |
| Cardiac | 96 | 0.00% | 0.24% |
| Unplanned Intubation | 96 | 0.00% | 0.05% |
| Renal Failure | 96 | 0.00% | 0.15% |
| Urinary Tract Infection (UTI) | 96 | 1.04% | 3.33% |
| Surgical Site Infection (SSI) | 96 | 0.00% | 0.27% |
| Sepsis | 96 | 1.04% | 0.65% |
| C. Diff Colitis | 96 | 0.00% | 0.08% |
| Unplanned Reoperation | 96 | 0.00% | 1.51% |
| Unplanned Readmission | 96 | 5.21% | 4.80% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
